Evidence map›Paper›PMID 25525472›Full record

ArticleMobile DNA2014

Distinct features of the piRNA pathway in somatic and germ cells: from piRNA cluster transcription to piRNA processing and amplification.

Emmanuelle Théron, Cynthia Dennis, Emilie Brasset, Chantal Vaury

Abstract read
In one paragraph

Article in Mobile DNA, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. International journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. What Drives Positive Selection in theThe Yale journal of biology and medicine · 2016
    Review
  19. piRNA pathway is not required for antiviral defense in Drosophila melanogaster.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emmanuelle Théron *Laboratoire GReD, Faculté de Médecine, Clermont Université, Université d'Auvergne, 28 Place H Dunant, 63000 Clermont-Ferrand, France.
Cynthia Dennis *Laboratoire GReD, Faculté de Médecine, Clermont Université, Université d'Auvergne, 28 Place H Dunant, 63000 Clermont-Ferrand, France.
Emilie BrassetLaboratoire GReD, Faculté de Médecine, Clermont Université, Université d'Auvergne, 28 Place H Dunant, 63000 Clermont-Ferrand, France.
Chantal VauryLaboratoire GReD, Faculté de Médecine, Clermont Université, Université d'Auvergne, 28 Place H Dunant, 63000 Clermont-Ferrand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transposable elements (TEs) are major components of genomes. Their mobilization may affect genomic expression and be a threat to genetic stability. This is why they have to be tightly regulated by a dedicated system. In the reproductive tissues of a large range of organisms, they are repressed by a subclass of small interfering RNAs called piRNAs (PIWI interacting RNAs). In Drosophila melanogaster, piRNAs are produced both in the ovarian germline cells and in their surrounding somatic cells. Accumulating evidence suggests that germinal and somatic piRNA pathways are far more different than previously thought. Here we review the current knowledge on piRNA production in both these cell types, and explore their similarities and differences.

Indexed as

Germline protectionpiRNA pathwayRNA silencingTransposable elements

Identifiers

PMID25525472
PMCPMC4269861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.